Semaglutide - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 308324Active ingredients:
Semaglutide
Dosage form:
Injection, solution
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800668626
|
Deletion from market:
31 Dec 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product has been replaced by ARTG 446290 - OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen.
Both presentations have been a-flagged, making them interchangeable on the PBS.
The PBS Supply Only listing for the 1.5 mL Ozempic 0.25 mg/0.5 mg pre-filled pen has been extended to 1 June 2026. This means the 1.5 mL presentation remains available for dispensing but not for prescribing.
An updated TGA web statement about Ozempic supply is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/ozempic-semaglutide-supply-information
|